Jump to content

Welcome to the new Traders Laboratory! Please bear with us as we finish the migration over the next few days. If you find any issues, want to leave feedback, get in touch with us, or offer suggestions please post to the Support forum here.

  • Welcome Guests

    Welcome. You are currently viewing the forum as a guest which does not give you access to all the great features at Traders Laboratory such as interacting with members, access to all forums, downloading attachments, and eligibility to win free giveaways. Registration is fast, simple and absolutely free. Create a FREE Traders Laboratory account here.

Stevenvegas

Stevenvegas Trades

By Stevenvegas, in Traders Log

Recommended Posts

Stevenvegas    10

Stevenvegas
Posted

big big day. BWIH up nicely off news and now DCMT which closed strong signs huge Pan Asia agreement!

 

Closed strong at .58

 

Document Capture Announces Milestone Pan-Asia Licensing Agreement

http://biz.yahoo.com/bw/090209/20090209006334.html?.v=1

 

Monday February 9, 4:01 pm ET

Far Reaching Sales Agreement between DCT and China-Based Syscan Technology Holdings

 

SAN JOSE, Calif.--(BUSINESS WIRE)--Document Capture Technologies, Inc. (OTCBB:DCMT - News), an IP-driven worldwide leader in the design, development and sale of next-generation portable scanning technologies, today announced a major product sales licensing agreement with China-based company Syscan Technology Holdings (STH).

 

 

STH is a leading manufacturer and provider of 2D barcode scanning technology, products and application solutions throughout China. For ten years STH and one of its wholly owned subsidiaries have worked closely with DCT: manufacturing its products exclusively. This logical broadening of that relationship is expected to result in the expansion of the international market for DCT mobile scanners.

 

“This is a major threshold event for Document Capture as it provides significant pan-Asian market expansion for DCT’s products directly into China and Southeast Asia as well as India, Pakistan and Malaysia,” said David P. Clark, Chief Executive Officer of DCT. “The growth of the security and financial sectors in these markets, as well as those more established in Korea, Japan, and Singapore are potentially some of the fastest growing in the world. To move into these areas with such a strong partner as STH is a major step in DCT’s corporate and revenue growth.”

 

The one-year renewable agreement covers DCT’s six DocketPORT® series products, as well as future offerings currently in development. DCT will also provide STH with Software Development Kits (SDK’s) covering PC, Linux, Mac, and Win CE operating systems. In addition the two companies will work together in the defending of the IP behind these devices worldwide.

 

As a shareholder, Syscan Technology Holdings currently owns over 3 million shares of DCT common stock. It is expected that the expanded relationship between the two companies will produce mutual opportunity for ongoing market development and expansion in Asia and beyond.

 

“This is a win-win joining of forces in the manufacturing sale and market expansion of mobile scanners globally.” Cheung Wei, Chairman of STH commented. “We believe there is great opportunity in China and other emerging markets.”

 

DCT’s commitment to product innovation has resulted in demand-driven products at the forefront of the paper-to-digital revolution. The proliferation of paper-to-digital green initiatives, high security demands and accelerated financial transactions require innovative ways to digitally capture, authenticate, store, share, and manage information.

Share this post

Link to post
Share on other sites

Stevenvegas    10

Stevenvegas
Posted

APPY news - Update

 

Update: AspenBio Pharma to Host Conference Call to Discuss Preliminary Results of the AppyScore FDA Clinical Study on Jan. 21 at 9:00 AM ET

 

CASTLE ROCK, CO--(MARKET WIRE)--Jan 20, 2009 -- AspenBio Pharma, Inc. (NasdaqCM:APPY - News), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, has changed the time for the conference call previously scheduled for Thursday, January 22, 2009 to now be held earlier, on Wednesday, January 21 at 9:00 a.m. Eastern time.

 

The company management will discuss initial preliminary data from its Food and Drug Administration clinical trial of AppyScore, the world's first blood-based test as an aid in the diagnosis of human appendicitis. They will also discuss status of the FDA approval, product development and commercialization of AppyScore.

 

AspenBio's Vice-Chairman Greg Pusey will host the call, with presentations by president and CEO, Richard G. Donnelly, the company's new executive chairman, Daryl J. Faulkner and Dr. John Bealer, the co-inventor of AppyScore. This will be followed by a question and answer period.

 

Please call the conference telephone number 5-10 minutes prior to the start time:

 

 

Date: Wednesday, January 21, 2009

Time: 9:00 a.m. Eastern time (6:00 a.m. Pacific time)

Dial in number, U.S./Canada Toll-free: 1-800-896-8445

International (Toll): 1-785-830-1916

Conference ID: 7ASPENBIO

 

An operator will register your name and organization and ask you to wait until the call begins. If you have any difficulty connecting with the conference call, please contact the Liolios Group at (949) 574-3860.

 

A simultaneous webcast and replay of the call will be accessible via this link: http://viavid.net/dce.aspx?sid=00005C74.

Share this post

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
Go To Topic Listing
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.

  I accept